SCHEMBL39049

SCHEMBL39049

CC(C)(C)OC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.61
KDM4E B2RXH2 2/20 0.61
LMNA P02545 2/20 0.61
FUT7 Q11130 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
GAA P10253 1/20 0.61
NFKB1 P19838 1/20 0.61
XDH P47989 1/20 0.61
GFER P55789 1/20 0.61
NFKB2 Q00653 1/20 0.61
RELA Q04206 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
SERPINE1 P05121 10/20 0.59
ESR1 P03372 2/20 0.49
POLA1 P09884 1/20 0.47
ANTXR2 P58335 1/20 0.47
NSD2 O96028 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199381 0.89 SERPINE1 (0.49) POLBKDM4ELMNAFUT7TDP1
SCHEMBL13243341 0.87 PTGS2 (0.61) POLBKDM4ELMNAFUT7TDP1
SCHEMBL13243342 0.86 SERPINE1 (0.44) POLBKDM4ELMNAFUT7TDP1
SCHEMBL7058435 0.84 CA12 (0.47) POLBKDM4ELMNAFUT7TDP1
SCHEMBL3312280 0.84 SERPINE1 (0.43) POLBKDM4ELMNAFUT7TDP1
SCHEMBL22072114 0.84 POLB (0.57) POLBKDM4ELMNAFUT7TDP1
SCHEMBL663524 0.84 SERPINE1 (0.43) POLBKDM4ELMNAFUT7TDP1
SCHEMBL13243343 0.84 SERPINE1 (0.43) POLBKDM4ELMNAFUT7TDP1
SCHEMBL5367737 0.83 SERPINE1 (0.44) POLBKDM4ELMNAFUT7TDP1
SCHEMBL27297570 0.82 ESR1 (0.50) POLBKDM4ELMNAFUT7TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119841360-A Method for preparing copper element doped nickel-iron-manganese precursor material and sodium battery positive electrode material thereof 中冶长天国际工程有限责任公司 2025-04-18 CN claimed
EP-1512323-B1 Microbicidal composition based on formaldehyde donor compounds and antioxidants AIR LIQUIDE SANTE INT (FR) 2007-02-21 EP claimed
US-20050054642-A1 Microbicidal composition based on formaldehyde donor compounds and antioxidants SCHULKE & MAYR GMBH (DE) 2005-03-10 US claimed
EP-1512323-A1 Microbicidal composition based on formaldehyde donor compounds and antioxidants Air Liquide Santé (International) (FR) 2005-03-09 EP claimed
US-4460674-A GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-07-17 US claimed
EP-3463481-B1 BIODEGRADABLE DENDRITIC STRUCTURE, METHODS AND USES THEREOF INEB INSTITUTO NAC DE ENGENHARIA BIOMEDICA (PT) 2025-04-30 EP disclosed
CN-119841360-A Method for preparing copper element doped nickel-iron-manganese precursor material and sodium battery positive electrode material thereof 中冶长天国际工程有限责任公司 2025-04-18 CN disclosed
CN-108535971-B Stripping liquid composition for removing photoresist 易案爱富科技有限公司 2023-09-12 CN disclosed
US-20230132202-A1 Polymeric Binder and High Molecular Weight Polymer Antifouling Compositions THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-04-27 US disclosed
US-11596662-B2 Passion flower seed extract, and cosmetic, pharmaceutical or dermatological compositions containing same LABORATOIRES EXPANSCIENCE (FR) 2023-03-07 US disclosed
US-20230024332-A1 Antifouling Polymeric Coating Compositions THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-01-26 US disclosed
CN-110824065-B Method for detecting embedded lycopene 南京中科药业有限公司 2022-07-26 CN disclosed
US-20060223806-A1 Microbicidal composition based on formaldehyde donor compounds and antioxidants SCHULKE & MAYR GMBH (DE) 2006-10-05 US disclosed
US-20050054642-A1 Microbicidal composition based on formaldehyde donor compounds and antioxidants SCHULKE & MAYR GMBH (DE) 2005-03-10 US disclosed
EP-1512323-A1 Microbicidal composition based on formaldehyde donor compounds and antioxidants Air Liquide Santé (International) (FR) 2005-03-09 EP disclosed
CN-1076972-C Basa agent and drug composition thereof which are taken through cutis HISAMITSU PHARMACEUTICAL CO (JP) 2002-01-02 CN disclosed
CN-1089507-A Base compositions and medicament composition thereof through the skin administration HISAMITSU PHARMACEUTICAL CO (JP) 1994-07-20 CN disclosed
US-5087548-A POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION JAPAN SYNTHETIC RUBBER CO., INC. (JP) 1992-02-11 US disclosed
EP-0227487-A2 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-07-01 EP disclosed
US-4460674-A GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11596662-B2 Passion flower seed extract, and cosmetic, pharmaceutical or dermatological compositions containing same CUTA, PGA5, TYR POLB 582/4885KDM4E 1899/4885LMNA 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.